During the past decade, Women's Cancer Care Associates LLC conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 29 clinical trials were completed, i.e. on average, 152.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 15 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Women's Cancer Care Associates LLC" #1 sponsor was "National Cancer Institute (NCI)" with 20 trials, followed by "Gynecologic Oncology Group" with 9 trials sponsored, "GOG Foundation" with 5 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Clovis Oncology, Inc." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Women's Cancer Care Associates LLC" #1 collaborator was "NRG Oncology" with 17 trials as a collaborator, "National Cancer Institute (NCI)" with 15 trials as a collaborator, "Gynecologic Oncology Group" with 4 trials as a collaborator, "GOG Foundation" with 3 trials as a collaborator and "Belgium and Luxembourg Gynaecological Oncology Group" with 2 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Women's Cancer Care Associates LLC" are "Ovarian Serous Adenocarcinoma" (8 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (7 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (7 trials), "Fallopian Tube Serous Adenocarcinoma" (7 trials) and "Fallopian Tube Transitional Cell Carcinoma" (7 trials). Many other conditions were trialed in "Women's Cancer Care Associates LLC" in a lesser frequency.

Most popular intervention types in "Women's Cancer Care Associates LLC" are "Drug" (45 trials), "Other" (27 trials), "Biological" (15 trials), "Procedure" (8 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (19 trials), "Laboratory Biomarker Analysis" (17 trials), "Quality-of-Life Assessment" (16 trials), "Carboplatin" (15 trials) and "Bevacizumab" (9 trials). Other intervention names were less common.

The vast majority of trials in "Women's Cancer Care Associates LLC" are 45 trials for "Female" genders and 4 trials for "All" genders.

Currently, there are NaN active trials in "Women's Cancer Care Associates LLC". undefined are not yet recruiting, 6 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Women's Cancer Care Associates LLC, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Women's Cancer Care Associates LLC, 2 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".